Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC – Get Free Report) traded up 0.4% during trading on Thursday . The stock traded as high as $30.85 and last traded at $30.72. 2,700 shares were traded during mid-day trading, a decline of 10% from the average session volume of 2,984 shares. The stock had previously closed at $30.60.
Virtus LifeSci Biotech Clinical Trials ETF Stock Up 1.1 %
The firm has a 50 day simple moving average of $28.64 and a 200 day simple moving average of $27.53.
About Virtus LifeSci Biotech Clinical Trials ETF
The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.
See Also
- Five stocks we like better than Virtus LifeSci Biotech Clinical Trials ETF
- How to Choose Top Rated Stocks
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Learn Technical Analysis Skills to Master the Stock Market
- MarketBeat Week in Review – 11/4 – 11/8
- Consumer Staples Stocks, Explained
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Virtus LifeSci Biotech Clinical Trials ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and related companies with MarketBeat.com's FREE daily email newsletter.
